This HTML5 document contains 43 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n7http://dx.doi.org/10.1001/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q84772264
rdf:type
wikibase:Item
schema:description
im August 2011 veröffentlichter wissenschaftlicher Artikel wetenschappelijk artikel article scientifique publié en 2011 наукова стаття, опублікована в серпні 2011 artículu científicu espublizáu n'agostu de 2011 scientific article published on 01 August 2011
p:P577
wds:Q84772264-603D5213-45D8-4999-BA90-565E4E1282D5
wdt:P577
2011-08-01T00:00:00Z
p:P2093
wds:Q84772264-65E28109-57D3-4C8F-8EBD-B42A57D5268C wds:Q84772264-ABE81EED-7F1B-401F-A32B-F9DC0C76FAF5 wds:Q84772264-4DFF1C75-9226-49A3-BC5C-B8C4B14510EA
wdt:P2093
Aieska De Souza Bruce E Strober Trisha Ali-Shaw
rdfs:label
Successful treatment of subacute lupus erythematosus with ustekinumab Successful treatment of subacute lupus erythematosus with ustekinumab
skos:prefLabel
Successful treatment of subacute lupus erythematosus with ustekinumab Successful treatment of subacute lupus erythematosus with ustekinumab
schema:name
Successful treatment of subacute lupus erythematosus with ustekinumab Successful treatment of subacute lupus erythematosus with ustekinumab
p:P50
wds:Q84772264-32234E05-4C4E-43D4-9A3C-E40C20C15D9A
wdt:P50
wd:Q37387663
p:P1476
wds:Q84772264-5A4A361C-CE33-4CC0-83B2-8BC20B5FBB0A
wdt:P1476
Successful treatment of subacute lupus erythematosus with ustekinumab
p:P304
wds:Q84772264-11F23CBE-DB31-4B2A-B3D3-49DB8083D353
wdt:P304
896-898
p:P31
wds:Q84772264-3CC071A0-0312-473C-A1DF-D147DC6C2D78
wdt:P31
wd:Q13442814
p:P921
wds:Q84772264-50D8D6FC-A66F-4E0D-A937-C0BED2DF3189
wdt:P921
wd:Q188297
p:P698
wds:Q84772264-5CC60B26-EEF3-40AA-AA35-1655BF753D45
wdtn:P698
n9:21844448
wdt:P698
21844448
p:P1433
wds:Q84772264-990314A4-6E05-4F32-906B-1A99BBF57B9D
wdt:P1433
wd:Q15749524
p:P433
wds:Q84772264-DCBDC3BA-7CAD-48DC-922F-21B99AD49A26
p:P478
wds:Q84772264-BC6CD6D2-FF68-452A-82A1-7DE0908F7B64
wdt:P433
8
wdt:P478
147
p:P356
wds:Q84772264-1DF0F54A-C7F4-49C8-BB70-E972B8F760DE
wdtn:P356
n7:ARCHDERMATOL.2011.185
wdt:P356
10.1001/ARCHDERMATOL.2011.185